BioCorRx (BICX) Profit After Tax (2010 - 2026)

BioCorRx has disclosed Profit After Tax across 17 years of filings, most recently posting -$859892.0 for Q1 2026.

• Profit After Tax for Q1 2026 came in at -$859892.0, down 2.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $46166.0 (up 100.96% YoY), and the FY2025 annual result was -$3.5 million, up 32.68% from the prior year.
• Profit After Tax came in at -$859892.0 for Q1 2026 at BioCorRx, down from -$471218.0 in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $1.4 million in Q2 2025 to a low of -$1.5 million in Q3 2024.
• The 5-year median for Profit After Tax is -$960007.5 (2022), against an average of -$883065.1.
• Across the five-year window, Profit After Tax slumped 71.49% in 2024 and jumped 211.61% in 2025, its largest moves.
• BioCorRx's Profit After Tax stood at -$1.2 million in 2022, then rose by 16.68% to -$969009.0 in 2023, then decreased by 26.69% to -$1.2 million in 2024, then surged by 61.62% to -$471218.0 in 2025, then tumbled by 82.48% to -$859892.0 in 2026.
• The last three Profit After Tax figures came in at -$859892.0 (Q1 2026), -$471218.0 (Q4 2025), and $1.4 million (Q2 2025), per Business Quant data.